Updated Stroke Guidelines Endorse Tenecteplase as Equivalent to Alteplase

New guidelines from the American Heart Association and American Stroke Association now recommend tenecteplase as an equally viable treatment option for acute ischemic stroke. This update applies within the 4.5-hour thrombolysis window, signifying a notable change in clinical practice for stroke management. The revised guidance offers clinicians more flexibility in treatment choices.